Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

Torres, T; Puig, L; Vender, R; Lynde, C; Piaserico, S; Carrascosa, JM; Gisondi, P; Dauden, E; Conrad, C; Mendes-Bastos, P; Ferreira, P; Leite, L; Lu, JSD; Valerio, J; Bruni, M; Messina, F; Nidegger, A; Llamas-Velasco, M; del Alcazar, E; Mufti, A; White, K; Caldarola, G; Teixeira, L; Romanelli, P; Desai, K; Gkalpakiotis, S; Romanelli, M; Yeung, JN; Nogueira, M; Chiricozzi, A

Torres, T (corresponding author), Ctr Hosp Univ Porto, Dept Dermatol, Porto, Portugal.; Torres, T (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, ; ():

Abstract

Background Drug survival analysis of biologic agents in psoriasis is of extreme importance, as it allows not only the evaluation of objective clinical......

Full Text Link